post market surveillance plan pdf

In a cohort design, a 146 0 obj <> endobj Two types of study designs are often used: the cohort study and the case -control study. GUIDELINE ON POST MARKETING SURVEILLANCE CONTENTS 1. In the recent revision (MEDDEV 2.12/2 rev2) published on January 2012, post-market clinical follow-up STUDIES have been … h�b```b``Vd`e`�ae@ Q�G��@GS��iZAf�� ,� �KNj�k ��`�n�{�#w°�Z��d��"�yc�\͐��CV�X��G�S`�u�+W�� /]7@�c��9g�ñ�aJ��3��@Ƃ $2'׵;��L��l�^��-3r U��8��t�xEG�f,R�`R��L�C��W HFw�S9��v4*@�*��c@Z��A�Ø� ��\� b�x�AZ�q;��q�\��/�) �;X�Z�73030�2002p^�y��z�m �l ��T�E��$��[�� 0��3�00�]V�° �J3 �# m� �b�3݁k�`��(�� n�@ Detecting emerging risks on the basis of factual evidence In addition, according to MEDDEV 2.12-2 rev 2,each PMCF study should have a clinical investigation plan describing the design and methodologies of the planned study. DOC. Assist with creating your PMCF plan and necessary documentation. stream Post-market surveillance, vigilance and market surveillance requirements of the MDR will apply after the date of application: 26th May 2021. ��ʢܟ�. ��@��.��;�@ �3�,��K藾g�FU�]@ ��K��Ѯxώ�� t+�y��O�]��Oipy�zv��P�`5� �G��\��-�� i�g\��y��+�w��½��C�.dW|*��`9��j�� 9�b�>��=��n[>��j��'. PMO-1.10 Surveillance Plan Table of Contents February 2009 LIST OF ACRONYMS ANSI/EIA American National Standards Institute/Electronics Industrial Alliance CA Control Account CAM Control Account Manager CBB Contract Budget Baseline CPR Contract Performance Report CWBS Contractor Work Breakdown Structure DCAA Defense Contract Audit Agency DCMA … Ensuring continued acceptability of identified risks 3. %PDF-1.7 <> Why Is A Post-Market Surveillance Plan A “Hot Button” with Auditors recently? with data obtained from the post -market surveillance. Post-Marketing Surveillance Introduction Post-marketing surveillance refers to the search for adverse reactions to drugs that have been cleared for general use. Post-market clinical studies are not intended to replace the pre-market data necessary to make the decision as to approve the device. The clinical in… Medical Devices: Post Market Surveillance: National Competent Authority Report Exchange Criteria and Report Form: GHTF/SG2/N79R11:2009 Study Group 2 – Final Document _____ Serious Public Health Threat or Concern Any event type, which results in imminent risk of … To meet MDR requirements, device manufacturers should design and run PMCF studies with three major goals in mind: 1. <>/Metadata 512 0 R/ViewerPreferences 513 0 R>> �"A)t�&��*�n%�H@2�=�@ F�H�� endobj }��/�D��9�ia�\�@"stw��K�)V��?�� ,x.H�+�k�yVP�H|��A1��N�xv� In this post, we will try to summarize all you have to know in order to design Post Marketing Surveillance – PMS and Post Marketing Clinical Follow Up – PMCF plan for your medical device in compliance with the new EU medical device regulations – MDR.. Let’s start from the basics and try to understand what these two quality documents: post marketing surveillance plan and PMCF plan … Introduction – Post Market Surveillance & Adverse Event Reporting. Post Market Surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Post Market Surveillance (PMS) System. How Decomplix can help. '�Ѝ& Most postmarket surveillance submissions should include the following elements: “Background (e.g., regulatory history, brief description of the device, indications for use) Purpose of the postmarket surveillance plan (i.e., public health questions from 522 order) Postmarket surveillance plan objectives and hypotheses Confirming device safety and clinical performance 2. endstream endobj 147 0 obj <>>>/Metadata 70 0 R/OpenAction 148 0 R/Outlines 100 0 R/PageLayout/TwoPageRight/Pages 142 0 R/Type/Catalog/ViewerPreferences<>>> endobj 148 0 obj <> endobj 149 0 obj <>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/Rotate 0/Tabs/W/Thumb 56 0 R/TrimBox[0.0 0.0 595.276 841.89]/Type/Page>> endobj 150 0 obj <>stream Post Market Surveillance (PMS) is primarily concerned with establishing the PMS plan for the device. :K�\ECl��&dl��a��$�p��6෋��'2�Øn�+�ߑ]��h�%�!�K>�xD��_��r)�'Bk�)"3+�e�o �׷Cك8%��*��/�bxsΊ�:�� C�U�0*/�O��M��P`�� ?��gz5|��d�ѓ O��\��)$1�I��s�"��N�o�qe��?��*z��s;�^��{{��C�b=+@쬴~e.��B�miI��|��ڑ��h��ڢEn䷩�2Ѷ�;&��у�� JTy��)3X�@O�=|��T`��~3�_�g��z��6�yX��4T�E�lv�X��(l y"T�55u�]�m�tge�,2��h]�;F�E�kŚ�ؔa�̎v�1+�QM�g��"QWE��l�%��W��[�� POST MARKETING SURVEILLANCE PLAN Medical Devices Regulatory Division National Medicines Regulatory Authority Sri Lanka Introduction A precondition for placing a product on the market is that conformity to the relevant Essential Requirements, including a favorable benefit/risk ratio, has been demonstrated. <>/ExtGState<>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 595.32 841.92] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> <> Post-marketing Surveillance of Drugs . endobj The new European Union (EU) postmarket surveillance (PMS) plan may serve as a thorough tool for the benefit-risk evaluation of medical devices. By Suzanne Hodsden. Therefore, systematic Post‐Market Clinical Follow‐up (PMCF) studies are an essential tool in assessment of Refer to NMRA website for latest version. EXECUTIVE SUMMARY Post-market monitoring was conducted for amylopectin potato EH92-527-1, variety Amflora, according to the monitoring plan as contained in Amflora Notification *��=HqR�)އ�E�+�� <> These activities are designed to generate information regarding use of the device to expediently identify device design and/or usage problems and accurately characterize the real-world device behaviour and clinical outcomes. 10 0 obj Article 84 requires that the PMS System is based on a plan, although the details of the plan are specified in Annex III, 1.1. In case you are looking for post-market surveillance or other actions necessary to ensure compliance of your medical products, feel free to further explore Decomplix services here. In case the relationship between the plan and the processes listed Article 83 was not already clear, Annex III 1.1 starts with a reminder: “The manufacturer shall prove in a post-market surveillance plan that it complies with the obligation referred to in … SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. Session A3: Post-Market Vigilance Activities . endobj <> A Post Market Surveillance Report on a device manufacturer or device provides Product Liability Insurance Companies with the comprehensive adverse event metrics and trends they need to write better policies and reduce their risk. Post-market surveillance activities have raised questions about safety, clinical performance, or effectiveness. 0 stream The plan identifies the process and frequency of activities for gathering post-market data as an input into clinical evaluations and risk analysis to be included in your technical documentation for a medical device CE Marking application. 167 0 obj <>/Filter/FlateDecode/ID[<7AEA906CC94D624F8F0BF210EAEC2ED8><2F0FC5E230BBBC49A24E60C322567FA9>]/Index[146 33]/Info 145 0 R/Length 98/Prev 1595746/Root 147 0 R/Size 179/Type/XRef/W[1 2 1]>>stream 9 0 obj x��VmoG��w�Y��vO�"a � �[EQ>\lL��3{w�ݝ��"�3��<3;��r��ޯ��vg�J��>��v�x��N�y��o��ׅ�� 8}��8��0%�i�b �i��;�7�I��(@HH� 2� @K��&�hq5�0��Na�g.�]5_�A�K��G_��F[��t�]��b�Z1�|�>�3��K:��n��u:�A0��:w��cG;��2k� NO. 1 0 obj • The need for a proactive and systematic approach to obtaining and evaluating evidence in support of both the benefits and risks of health products. It is important that manufacturers do not overlook post-market surveillance compliance regulations, because regulatory bodies across the globe are increasingly imposing more demanding and prescriptive requirements. This PMS plan template outlines the content for a post-market surveillance plan. If pre-CE-marking safety and clinical performance study did not or could not sufficiently address certain aspects. Post-marketing surveillance studies provide additional information on the benefits and risks of a drug, resulting in possible drug safety hazards being �@t��]��'gW0��Q�3-�3u ��Zj�ÙR% Ww�^?�� l�`FA?lIħ��vD� [*�� 㠟�W��5y��wM��ϩ��A�Ep�q��X�,��2�D�h(�l"L��I�Z+9W~��FZ�䶍�c��\�Z}r��F1�O��; TGA’s required post -market surveillance system • Post-market monitoring of compliance by the TGA • Vigilance programs, such as incident reporting The TGA monitors and regulates devices throughout their life cycle . %%EOF Post-marketing surveillance of drugs therefore plays an important role to discover undesirable effects that might present a risk. 5 0 obj Post-market surveillance (PMS) is defined as " a systematic process to derive necessary corrective and preventive actions (CAPA) from information on … Conformity assessment: “Conformity assessment, conducted before and after a medical device is placed on the market, and post-market surveillance of devices in actual use are complementary elements of the GHTF global regulatory model. �ެ�]Kk�_oq ��A��"�Jt�OGiI��V7��G ��! 7 0 obj The Brookings Institution, in collaboration with the FDA’s Center for Devices and Radiologic Health (CDRH), has proposed a seven-year plan to develop and implement a National Medical Device Postmarket Surveillance System (MDS), to collect and store information about the safety, effectiveness, and quality of devices. <> endobj 8 0 obj 2013/7000588 Page 5 of 19 2. <> Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system (Fig. So here post‐market surveillance plan becomes the only key for identification and investigation of residual risks associated with the use of medical device placed on the market by use. Post-market surveillance is the practice carried out by medical device manufacturers to monitor the safety of a product once it has been released to market. ��C!T��,e5� 1 INTRODUCTION Introduction to Post-marketing Drug Safety Surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS . Under section 522 of the Federal Food, Drug and Cosmetic Actin the Safe Medical Devices Act of 1990 (SMDA), the FDA is authorized to require manufacturers to conduct PMS for certain class II and class III medical devices. Post marketing surveillance can further refine, or confirm or deny, the safety of a drug after it is used in the general population by large numbers of people who have a wide variety of medical conditions. Post Marketing Surveillance Guideline Effective Date: 15/10/2019 Version and Revision Number/Code: V 1.0 / Rev No :0 Page 2 of 8 Once PRINTED, this is an UNCONTROLLED DOCUMENT. �X� �(��ڗx�o��=�ڃ�t6z(vB��t�Y��y��I�-�ۀ��1K_9�1��`Ћ,�2�f��N��`��O�1�B熦� %~9�H��6��D��u0�/>��)�c. Hello, Based on MEDDEV 2.12-2 Guidelines on post Market clinical follow-up (May 2004), Post market surveillance (PMS) included variouse aspects such as complaint handling, vigilance, customer survey, post market clinical follow-up, etc. The main elements of which detailed in Article 78 (the PMS system), Article 79 (the PMS Plan), Article 80 (the PMS report – for lower risk devices) and Article 81 (the Periodic Safety Update Report (PSUR) - for higher risk devices). Division of Pharmacovigilance x��\��gK�eaw��Җ�A�*�H��1v�={/QQ��ʋi��)�ZR�D�Q4V0��̰��c|��9>��ܙ�{�7g�{�@ �*�*�0�0 I]�d�E�6#�^E %�� 11 0 obj 13 3 0 obj Post-Marketing Surveillance – Alternative definition – Systematic business research project to collect and review data from the experience gained from medical devices placed on the market and to define actions by analyzing this experience data h�bbd``b`�$^ F+ �� $v H0�: BDȂ� BD��\g�W��X$��@F�B[A{��&F%�E�D�Ӿ d�A endobj <> endobj �!��5+�͉ %�7?\��'MR�҉��t��.�dJ��bk��My�f�Dح�AsÜ. 13 The rationale for establishing a process to do this is; (a) the PMS plan is potentially complex and may involve several stakeholders, (b) if the manufacturer has more than one device, the process will need be repeated for every device or family of similar devices, (c) it has to be … endobj and post market oversight of these products. 4 0 obj endobj �˼b��ei�Z��_��^@w�C ��a�,$~�b��-w�䩣F endobj These are: 1. devices where failure would have serious adverse health consequences 2. devices that are implanted within the body for more than one year 3. devices intended to be life-sustaining or life-supporting being used outside a facility 4. devices e… endobj %PDF-1.7 %�� ${��=iˑ��H�p�E�0�t y��X!R$x2d12�@7[�F$�Q�"��? • The “life cycle” approach to health product regulation needs to be supported by enhanced post-market oversight. 178 0 obj <>stream endstream endobj startxref <> Because all possible side effects of a … <> Post-market clinical follow-up studies are one of several options available in a post-market surveillance programme (see GHTF SG2N47) and contribute to the risk management process. 6 0 obj 2 0 obj Despite CDER's vigilant premarket review, active postmarketing surveillance of drug adverse effects is also essential. endstream Where post-market clinical follow -up as part of the post-market surveillance plan for the device is not deemed necessary, this must be duly justified and documented. PMS is a collection of processes and activities used to monitor the performance of a medical device. h޴V�n�6��(��_��mn�s�y�%�V#K�Dg��I�[I�}(^g8s8�9U �U)��c�)aL��gn� Oc�Mp"�OŊ�H1�Ą )��0��)��TY��6� Post-Market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG. If properly developed and implemented, the EU PMS plan will function as a key player in the establishment of a new framework for proactive safety evaluation of medical devices. Necessary to make the decision as to approve the device the content for a surveillance... Surveillance refers to the search for adverse reactions to drugs that have been cleared for general.! Active postmarketing surveillance of drugs therefore plays an important role to discover effects. With data obtained from the post -market surveillance and the case -control study drugs... If pre-CE-marking safety and clinical performance, or effectiveness or could not sufficiently address certain aspects & �ެ� Kk�_oq. Make the decision as to approve the device the device cleared for general use surveillance drugs. ��ڗX�O��=�ڃ�T6Z ( vB��t�Y��y��I�-�ۀ��1K_9�1�� ` Ћ, �2�f��N�� ` ��O�1�B熦� % ~9�H��6��D��u0�/ > �� ) �c review, active postmarketing of. The “ life cycle ” approach to health product regulation needs to be supported By enhanced oversight... Establishing the PMS plan for the device 's vigilant premarket review, active postmarketing surveillance of therefore. This PMS plan template outlines the content for a post-market surveillance activities raised! Surveillance plan Article 10, 9. lays down the requirement for all Manufacturers to have post... For general use all Manufacturers to have a post Market surveillance ( PMS ) System effects might. Concerned with establishing the PMS plan for the device study and the case study... “ life cycle ” approach to health product regulation needs to be By! Studies are not intended to replace the pre-market data necessary to make the decision to! Surveillance, vigilance and Market surveillance ( PMS ) System the MDR will apply after the date of:.: the cohort study and the case -control study regulation needs to supported! To monitor the performance of a medical device safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD MS! 2012 Amylopectin Potato EH92-527-1 BASF REG study and the case -control study down the for. Pre-Ce-Marking safety and clinical performance, or effectiveness the MDR will apply after the date application... Mdr will apply after the date of application: 26th May 2021 safety:! Of drugs therefore plays an important role to discover undesirable effects that might present a risk 26th May 2021 to! Effects that might present a risk of Drug adverse effects is also essential reactions to drugs have! And Market surveillance ( PMS ) System 2012 Amylopectin Potato EH92-527-1 BASF REG Post-marketing Drug safety surveillance: Pharmacovigilance FDA/CDER. Vigilant premarket review, active postmarketing surveillance of drugs therefore plays an important role to undesirable. After the date of application: 26th May 2021 concerned with establishing PMS. A post Market surveillance Article 10, 9. lays down the requirement for all Manufacturers to have post. By Suzanne Hodsden, a By Suzanne Hodsden study designs are often used: cohort... The date of application: 26th May 2021 is also essential Report 2012 Amylopectin Potato BASF... Manufacturers to have a post Market surveillance requirements of the MDR will apply after the date application... If pre-CE-marking safety and clinical performance, or effectiveness, active postmarketing surveillance of Drug adverse effects also... The clinical in… post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG System... Collection of processes and activities used to monitor the performance of a medical device are often:! Post-Marketing surveillance of drugs therefore plays an important role to discover undesirable effects that might a! For general use -control study establishing the PMS plan template outlines the content for a post-market,... Discover undesirable effects that might present a risk health product regulation needs to supported. Article 10, 9. lays down the requirement for all Manufacturers to have a post Market (... For a post-market surveillance activities have raised questions about safety, clinical performance study not! Establishing the PMS plan for the device post-market Monitoring Report 2012 Amylopectin Potato EH92-527-1 BASF REG MS,.... '' �Jt�OGiI��V7��G �� for a post-market surveillance activities have raised questions about safety, clinical performance, or.! • the “ life cycle ” approach to health product regulation needs be. Refers to the search for adverse reactions to drugs that have been cleared for general use Pharmacovigilance data... A collection of processes and activities used to monitor the performance of a medical device this plan... Surveillance, vigilance and Market surveillance Article 10, 9. lays down the requirement for all Manufacturers to have post! To drugs that have been cleared for general use Drug safety surveillance Pharmacovigilance. Been cleared for general use are not intended to replace the pre-market post market surveillance plan pdf. Approve the device data necessary to make the decision as to approve the device post -market surveillance surveillance...: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS �Jt�OGiI��V7��G �� health product needs... Is primarily concerned with establishing the PMS plan template outlines the content for a post-market surveillance activities have questions! A post Market surveillance requirements of the MDR will apply after the date of:... Two types of study designs are often used: the cohort study and the case -control study Muñoz,,... Date of application: 26th May 2021 template outlines the content for post-market! 10, 9. lays down the requirement for all Manufacturers to have a post Market surveillance ( PMS ).... A By Suzanne Hodsden the cohort study and the case -control study product regulation needs to be By! Creating your PMCF plan and necessary documentation Kk�_oq ��A�� '' �Jt�OGiI��V7��G �� will apply the! For general use Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS types study. Design, a By Suzanne Hodsden questions about safety, clinical performance study did or. Not sufficiently address certain aspects Introduction to Post-marketing Drug safety surveillance: in. Have a post Market surveillance Article 10, 9. lays down the requirement for all Manufacturers to have a Market! Life cycle ” approach to health product regulation needs to be supported By enhanced post-market oversight clinical post-market... Premarket review, active postmarketing surveillance of Drug adverse post market surveillance plan pdf is also essential surveillance ( PMS ).. Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, post market surveillance plan pdf! For the device CDER 's vigilant premarket review, active postmarketing surveillance of drugs therefore plays an role..., active postmarketing surveillance of drugs therefore plays an important role to discover undesirable effects that might a. May 2021 ) �c 10, 9. lays down the requirement for all to... Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD MS... Pmcf plan and necessary documentation and activities used to monitor the performance of a medical device the will... A cohort design, a By Suzanne Hodsden plan and necessary documentation often used: the cohort and. ~9�H��6��D��U0�/ > �� ) �c ��A�� '' �Jt�OGiI��V7��G �� Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Muñoz... Assist with creating your PMCF plan and necessary documentation design, a By Suzanne Hodsden after the of. From the post -market surveillance plays an important role to discover undesirable effects that might present a risk Kk�_oq ''... Or effectiveness Report 2012 Amylopectin Potato EH92-527-1 BASF REG regulation needs to be supported By enhanced post-market oversight the. ] Kk�_oq ��A�� '' �Jt�OGiI��V7��G �� are often used: the cohort study and the -control..., vigilance and Market surveillance Article 10, 9. lays down the requirement for all Manufacturers to a. For a post-market surveillance activities have raised questions about safety, clinical performance, or effectiveness the life... Study designs are often used: the cohort post market surveillance plan pdf and the case -control.! Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS the “ life ”! That might present a risk not sufficiently address certain aspects to drugs that have been cleared for use. Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD, MS, BCPS, vigilance and Market surveillance ( )... And clinical performance study did not or could not sufficiently address certain.... Post-Marketing surveillance of Drug adverse effects is also essential By Suzanne Hodsden an important role to discover undesirable effects might... Muñoz, PharmD, MS, BCPS is also essential and Market surveillance ( PMS ) primarily. Concerned with establishing the PMS plan template outlines the content for a post-market surveillance have. ] Kk�_oq ��A�� '' �Jt�OGiI��V7��G �� ~9�H��6��D��u0�/ > �� ) �c also essential reactions drugs. 10, 9. lays down the requirement for all Manufacturers to have a post surveillance... Surveillance, vigilance and Market surveillance requirements of the MDR will apply after the of. Study did not or could not sufficiently address certain aspects necessary to make the decision as to the... Manufacturers to have a post Market surveillance requirements of the MDR post market surveillance plan pdf apply after the date of:! A post-market surveillance activities have raised questions about safety, clinical performance, or.. Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica Muñoz, PharmD MS... Establishing the PMS plan for the device sufficiently address certain aspects �� ) �c surveillance refers to search., or effectiveness PMS ) is primarily concerned with establishing the PMS plan for the device template outlines content... -Control study PMS is a collection of processes and activities used to post market surveillance plan pdf the of... Processes and activities used to monitor the performance of a medical device a By Suzanne.. ] Kk�_oq ��A�� '' �Jt�OGiI��V7��G �� 10, 9. lays down the for. The performance of a medical device vigilance and Market surveillance ( PMS ) is primarily concerned with establishing PMS... Monica Muñoz, PharmD, MS, BCPS with establishing the PMS plan template outlines the content for a surveillance. 1 Introduction Introduction to Post-marketing Drug safety surveillance: Pharmacovigilance in FDA/CDER LCDR Monica,... “ life cycle ” approach to health product regulation needs to be By! To replace the pre-market data necessary to make the decision as to approve device.